Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum.
about
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsisTrends in vital signs and routine biomarkers in patients with sepsis during resuscitation in the emergency department: a prospective observational pilot studyMortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial.Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trialsEarly increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsisImpact of introducing multiple evidence-based clinical practice protocols in a medical intensive care unit: a retrospective cohort study.Predictors of mortality of severe sepsis among adult patients in the medical Intensive Care Unit.Citation analysis did not provide a reliable assessment of core outcome set uptakeBench-to-bedside review: Targeting antioxidants to mitochondria in sepsis.Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort studyMitochondrial Targeted Endonuclease III DNA Repair Enzyme Protects against Ventilator Induced Lung Injury in Mice.Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis.Sepsis progression and outcome: a dynamical model.Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsisPlasma DNA concentration as a predictor of mortality and sepsis in critically ill patients.Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma.Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury.Decreased mortality resulting from a multicomponent intervention in a tertiary care medical intensive care unit.Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 scoreSimultaneous Prediction of New Morbidity, Mortality, and Survival Without New Morbidity From Pediatric Intensive Care: A New Paradigm for Outcomes Assessment.Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.Statin research in critical illness: hampered by poor trial design?Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis.Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.Metabolic theory of septic shock.Sepsis: frontiers in supportive care, organisation and research.Inhibition of acute lung injury by rubriflordilactone in LPS-induced rat model through suppression of inflammatory factor expression.Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia.Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability.The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die.Protective Role of Liriodendrin in Sepsis-Induced Acute Lung Injury.Steroids in late ARDS?Moving beyond the assessment of mortality and severity of diseases in critical patients: we are just getting started..Interleukin 6 increases dysfunction of organs in sepsis rats through sirtuin 1.Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.Predictors of mortality in patients with severe sepsis admitted to an ICU.BISON (Bloodstream Infections and Sepsis Outcomes measurement Network) initiative: an ESGBIS proposal.Effects of organoselenium compounds on early and late brain biochemical alterations in sepsis-survivor rats.Trends in vital signs and routine biomarkers in sepsis patients during resuscitation in the emergency department: a prospective observational pilot study.Clinical Trials in Pediatric Sepsis: What's the (End) Point?
P2860
Q24622152-F9947C6D-74A2-49CF-BF17-99F559D96F05Q24658662-57249187-1AEA-4EE4-AAC5-C350FE0D0ACDQ30423714-0D53711E-E029-46B0-A5CE-FEBB66954620Q30489561-52C84CBC-B4AE-4D18-ADC0-9F967F7A9921Q30493116-6B3FE2EF-1305-48DE-BDC3-025E9E1A821CQ33293620-C7A3B94F-99EA-48B2-B30D-E7D0571DE547Q33443232-D6E121A6-60ED-4E31-81CD-2B17B7DD27B1Q33910843-6232867F-7762-4368-93EF-F8FF3BADB3D7Q34153200-94892F0F-D32C-4F03-9E87-779FD89F35F9Q34192279-E36EAB08-4A00-4F37-8C17-4A128A2AE3EDQ34203299-BE11F92B-7415-4D17-A76D-E4B0D278EEDCQ34424217-17D718B2-BA0A-44C2-B4A0-586A17BACCC7Q34496641-3B594E7A-3604-4EF6-9642-0640D913249FQ34788841-EB291884-B3B1-4CB9-B5DB-0EBDA0CE8B59Q34999508-07BE1C11-0D5B-41FD-90EA-F2AAF20CC274Q35544733-879DE02D-034F-4CA3-9573-72758889CEDBQ35889075-AE4D8B70-15F1-4339-A9AE-496E3E3A5397Q36059931-5E560200-30B4-4ED1-8038-BF96FE9E42B3Q36060518-EECDBE70-E864-41B4-A19C-15B9F10C3C84Q36311519-02E9D2E4-8AEA-4240-AE9F-3CBAE3A2968CQ36889928-5C12F247-6B52-47D4-A92B-8D79C852026EQ37657764-99F2E370-4170-4CF4-A538-C59F2D40D057Q37755268-7F4CD934-5A1D-46B7-8F2B-A1D3CDB4FD89Q37978478-B1616729-4789-4289-AE33-BEDBAB675B63Q38217239-DDDF8724-46B7-4578-B733-A2BEC2515DA9Q38764864-ECE44333-5573-405C-B3E0-2D544538D73CQ38793555-4458054C-CB2E-4581-B7AB-598A67C12CC3Q38905183-772F2E9C-6C59-4804-862F-427CC77BAE68Q39500397-F9060BDC-A560-4050-A535-D49153CBE8BFQ40183960-B5BE3396-F919-4D6D-961B-B97CF54616D1Q40585749-BD67B9AF-BC58-45D7-AE19-3441CB2A51BCQ42111189-305BCD32-25A5-4C44-8CDF-E75F630A159FQ42586538-BCADC196-989E-46BA-8CC5-BB69F565883EQ42965142-F66B3A68-A465-4292-BD73-E14A3FC4C4B7Q45015016-E869D342-B5ED-408D-B666-AC1223EC53F0Q46052365-E1F24F76-F8DE-4E6B-A8B7-563A17C1530DQ46170480-3F7437E5-CC11-4F7D-9CF0-E44A319D0A24Q46894653-8FBDF498-C9EA-44ED-B464-350A3A685BE6Q53729622-87CBBDB9-C2F1-4A88-9C22-1E324AF80ABAQ55275350-A5D43616-2423-4019-8DD0-E55637D664AC
P2860
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Outcome measures for clinical ...... he International Sepsis Forum.
@ast
Outcome measures for clinical ...... he International Sepsis Forum.
@en
type
label
Outcome measures for clinical ...... he International Sepsis Forum.
@ast
Outcome measures for clinical ...... he International Sepsis Forum.
@en
prefLabel
Outcome measures for clinical ...... he International Sepsis Forum.
@ast
Outcome measures for clinical ...... he International Sepsis Forum.
@en
P2093
P50
P1476
Outcome measures for clinical ...... he International Sepsis Forum.
@en
P2093
Claire Bombardier
Edward Abraham
Gordon Bernard
Henrik Stig Jørgensen
John C Marshall
Maarten Boers
Richard Sylvester
P304
P356
10.1097/01.CCM.0000174478.70338.03
P407
P577
2005-08-01T00:00:00Z